All studies
Enrolling by invitationOBSERVATIONAL

Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

Kidneys filter waste from the blood, but newborn babies in neonatal intensive care units (NICUs) can sometimes experience sudden kidney stress, known as acute kidney injury (AKI). A worldwide study in 2014 first showed how common this was, but neonatal care has progressed since then. The AWAKEN 2.0 study looks back at medical records from babies treated in specialised neonatal units across the world between January and March 2019. It focuses on babies who received fluids through a drip for at least 48 hours. By reviewing these past records, researchers want to see if kidney problems have become more widely recognised and how they affect hospital stay lengths and survival. Because this study only reviews existing medical charts, babies do not need any new treatments, extra tests, or hospital appointments.

At a glance

Status
Enrolling by invitation
Sponsor
Indiana University
Enrolment target
8,000
Start
01 Mar 2025
Estimated completion
01 Jun 2027

What is this study about?

The kidneys have an essential job: they clean waste from the blood and keep fluids balanced. In newborn babies—especially those born early or who need intensive care—the kidneys are still developing and can be delicate. Sometimes, illness or treatments can cause sudden strain on the kidneys, known as acute kidney injury (AKI). This can lead to longer hospital stays and may raise the risk of kidney problems later in childhood.

About ten years ago, a landmark international study called AWAKEN showed that kidney strain in neonatal units was surprisingly common. However, neonatal medicine has improved since then. Doctors now watch kidney health more closely and have developed gentler care strategies. AWAKEN 2.0 is designed to update that picture by looking at a wider group of hospitals across the world.

In this study, researchers are reviewing the medical records of babies treated in specialised neonatal intensive care units (NICUs) during early 2019. They want to find out how often kidney injury occurred and how it was linked to the baby's overall recovery, length of hospital stay, and kidney health when going home.

The ultimate goal is to give doctors clearer, up-to-date evidence. By understanding which newborn babies face the highest risk, medical teams can spot kidney strain sooner, tailor treatments safely, and better protect children's long-term health.

Key takeaways

  • AWAKEN 2.0 reviews hospital records to study kidney health in newborn babies.
  • The study focuses on infants treated in neonatal intensive care units (NICUs) between January and March 2019.
  • Eligible records belong to babies who needed an intravenous drip for at least 48 hours.
  • There are no active clinic visits, experimental treatments, or extra tests involved.
  • The findings will help neonatal teams improve kidney care and safety for future newborns.

Who may be eligible?

This study focuses on newborn babies who were cared for in a specialised neonatal intensive care unit (a level 3 or level 4 NICU) between 1 January and 31 March 2019. To be included in the review, the infant must have received fluids through an intravenous (IV) drip for more than 48 hours during their stay.

Babies were not included if they were older than two weeks (14 days) when admitted to the unit. The review also excludes babies who had serious heart conditions requiring surgery or a hospital transfer within their first week, those with life-limiting genetic conditions, or babies who sadly passed away within the first 48 hours of birth.

Because AWAKEN 2.0 is a 'retrospective' study, it only analyses records that were already written down in 2019. It does not enrol new babies for active treatment today.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Baby was cared for in a participating neonatal intensive care unit (NICU).
  2. Admission occurred between 1 January 2019 and 31 March 2019.
  3. Baby was admitted within their first 14 days of life.
  4. Baby received fluids through an intravenous (IV) drip for more than 48 hours.
  5. Baby did not have major heart surgery or a life-limiting genetic condition in the first week.
Answer every question to see your result.

What does participation involve?

Taking part in this study does not involve any clinic visits, appointments, or active tests. Because researchers are looking back at care provided in early 2019, parents do not need to do anything, and babies will not receive any experimental drugs or procedures.

Researchers simply collect information already recorded in the hospital charts. This includes birth weight, how long the baby stayed in hospital, fluid intake through drips, and the results of routine blood and urine tests. There is no ongoing follow-up or time commitment for families.

Potential risks and benefits

Because this study only examines past medical charts, there are no physical risks or changes to your baby's healthcare. The main priority is data privacy. All medical details are kept strictly confidential, anonymised, and stored securely under strict data protection laws. While this study does not offer direct personal benefits to the babies whose charts are reviewed, it provides valuable insights that can help doctors better protect the kidneys of newborn babies in the future. Parents generally have the right to opt out of health records research if they wish.

Locations (125)

  • University of Alabama at Birmingham
    Verified postcode
    Birmingham, United States
  • University of Arkansas for Medical Sciences
    Verified postcode
    Little Rock, United States
  • Stanford Children's
    Verified postcode
    Palo Alto, United States
  • Rady Children's Hospital/UCSD
    Verified postcode
    San Diego, United States
  • Children's Hospital Colorado
    Verified postcode
    Aurora, United States
  • Connecticut Children's Medical Center
    Verified postcode
    Hartford, United States
  • Yale University
    Verified postcode
    New Haven, United States
  • Children's National Hospital
    Verified postcode
    Washington D.C., United States
  • Miami Children's / Nichlaus Children's Hospital
    Verified postcode
    Miami, United States
  • Baptist Health South Florida/South Miami Hospital
    Verified postcode
    South Miami, United States
  • Emory Healthcare / Children's Healthcare of Atlanta
    Verified postcode
    Atlanta, United States
  • Children's Hospital of Georgia
    Verified postcode
    Augusta, United States

Common questions

What is acute kidney injury (AKI) in a newborn?

AKI means a baby's kidneys have suffered sudden stress or a temporary drop in their ability to filter blood and balance fluids.

Will my baby need any tests or new medications for this study?

No. This study only reviews past medical notes from early 2019. No blood tests, scans, or medications are given.

Can my baby join this trial right now?

No. AWAKEN 2.0 is an observational study that only reviews records from babies who were in hospital between January and March 2019.

How is my baby's confidential data protected?

All identifying information, such as names and addresses, is removed or replaced with a code. Researchers handle all files according to strict legal privacy standards.

Why are researchers looking at data from 2019?

Care for newborn babies changes rapidly. Looking at records from 2019 helps doctors see if newer practices have reduced kidney problems compared to older data from 2014.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Assessment of Worldwide Acute Kidney Injury Epidemiology in …" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.